Select an option to learn more
INDICATIONS: INLYTA is a prescription medicine used to treat kidney cancer that has spread or cannot be removed by surgery (advanced renal cell carcinoma or RCC) in combination with pembrolizumab as your first treatment, or alone when 1 prior drug treatment regimen for your RCC has not worked. It is not known if INLYTA is safe and effective in children.
Eligible, commercially insured patients may pay as little as $0 per month for INLYTA. Limits, terms, and conditions apply.* Patients may receive up to $9,450 per product in savings annually.
GET STARTED
Advanced renal cell carcinoma (RCC) is kidney cancer that has spread or cannot be removed by surgery.
LEARN MORE
INLYTA Insiders provides resources and information to help you stay on track while you are on INLYTA with pembrolizumab.
SIGN UP
Brochures and tools to help you learn more about INLYTA and advanced RCC.
EXPLORE NOW
*Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. Patients may receive up to $9,450 per product in savings annually. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. Pfizer reserves the right to rescind, revoke, or amend this offer without notice. For any questions, please call 1-877-744-5675, visit PfizerOncologyTogether.com/terms or write: Pfizer Oncology Together Co-Pay Savings Program, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560.
Before taking INLYTA, tell your healthcare provider about all of your medical conditions, including if you:
For females, tell your healthcare provider if you:
For males with female partners who are able to become pregnant:
INLYTA may cause fertility problems in males and females, which may affect your ability to have a child. Talk to your healthcare provider if this is a concern for you.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. INLYTA and certain other medicines can affect each other causing serious side effects.
Talk with your healthcare provider before you start taking any new medicine. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
Do not drink grapefruit juice or eat grapefruit. Grapefruit may increase the amount of INLYTA in your blood.
INLYTA may cause serious side effects, including:
The most common side effects of INLYTA with pembrolizumab include:
Important information: If your healthcare provider prescribes INLYTA for you to be taken with pembrolizumab, also read the Medication Guide for pembrolizumab.
The most common side effects of INLYTA when used alone include:
These are not all of the possible side effects of INLYTA. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information and Patient Information, which includes a complete discussion of the risks of INLYTA.
INLYTA is a prescription medicine used to treat kidney cancer that has spread or cannot be removed by surgery (advanced renal cell carcinoma or RCC):
It is not known if INLYTA is safe and effective in children.
INLYTA is a prescription medicine used to treat kidney cancer that has spread or cannot be removed by surgery (advanced renal cell carcinoma or RCC):
It is not known if INLYTA is safe and effective in children.
A mass of cancer cells.
A disease of the arteries (commonly called high blood pressure).
Located throughout the body, lymph nodes filter lymph fluid. They store special cells that can trap cancer cells or bacteria that are traveling through the body in the lymph.
One of a pair of organs that removes waste products from the blood. In the process, they make urine to help carry waste products out of the body. One is on the left side of the abdomen. The other is on the right side.
INLYTA (axitinib) is a prescription medicine used to treat kidney cancer that has spread or cannot be removed by surgery (advanced renal cell carcinoma or RCC):
It is not known if INLYTA is safe and effective in children.
Cancer that has spread from one part of the body to another through the lymphatic system or bloodstream.